Long-Term Study Suggests Extended Relief from Atopic Dermatitis After Topical Treatment
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.